Artwork

内容由Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick提供。所有播客内容(包括剧集、图形和播客描述)均由 Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Episode 94 - Top Papers from the 2024 European Society of Cardiology Congress

28:51
 
分享
 

Manage episode 447749960 series 3323674
内容由Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick提供。所有播客内容(包括剧集、图形和播客描述)均由 Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Welcome back Rounds Table Listeners!

We are back today with a special Rapid Fire Podcast!

This week, Drs. Mike Fralick and Justin Boyle discuss top papers from the 2024 European of Society of Cardiology Congress. Here we go!

  1. Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease (0:00 – 9:25).
  2. Beta-Blocker Interruption or Continuation after Myocardial Infarction (9:25 – 13:52).
  3. Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (13:52 – 21:20).
  4. Continuation vs. Discontinuation of Renin-Angiotensin System Inhibitors Before Major Non-Cardiac Surgery (21:20 – 28:51).

Of note, for prescribers in Ontario, there is now a limited use code for finerenone for patients that have both T2DM and CKD.

Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods

  continue reading

346集单集

Artwork
icon分享
 
Manage episode 447749960 series 3323674
内容由Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick提供。所有播客内容(包括剧集、图形和播客描述)均由 Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Welcome back Rounds Table Listeners!

We are back today with a special Rapid Fire Podcast!

This week, Drs. Mike Fralick and Justin Boyle discuss top papers from the 2024 European of Society of Cardiology Congress. Here we go!

  1. Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease (0:00 – 9:25).
  2. Beta-Blocker Interruption or Continuation after Myocardial Infarction (9:25 – 13:52).
  3. Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (13:52 – 21:20).
  4. Continuation vs. Discontinuation of Renin-Angiotensin System Inhibitors Before Major Non-Cardiac Surgery (21:20 – 28:51).

Of note, for prescribers in Ontario, there is now a limited use code for finerenone for patients that have both T2DM and CKD.

Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods

  continue reading

346集单集

所有剧集

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南